VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $602,000 | +336.2% | 25,917 | +107.1% | 0.23% | +303.5% |
| Q1 2017 | $138,000 | -24.2% | 12,517 | 0.0% | 0.06% | -31.3% |
| Q4 2016 | $182,000 | -40.7% | 12,517 | 0.0% | 0.08% | -38.1% |
| Q3 2016 | $307,000 | +21.8% | 12,517 | 0.0% | 0.13% | +26.4% |
| Q2 2016 | $252,000 | -23.4% | 12,517 | 0.0% | 0.11% | -28.4% |
| Q1 2016 | $329,000 | -74.1% | 12,517 | 0.0% | 0.15% | -75.3% |
| Q4 2015 | $1,272,000 | -68.8% | 12,517 | -22.0% | 0.60% | -64.4% |
| Q3 2015 | $4,081,000 | 0.0% | 16,050 | 0.0% | 1.68% | 0.0% |
| Q2 2015 | $4,081,000 | +12.3% | 16,050 | -12.3% | 1.68% | +105.8% |
| Q1 2015 | $3,635,000 | – | 18,300 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |